Sanofi delayed drug to avoid $708 in milestone lawsuit
Nov 10, 2015 13:13:53 GMT -5
saxcmann and wmdhunt like this
Post by nialla44 on Nov 10, 2015 13:13:53 GMT -5
I didn't see this posted on proboards.
Sounds like a potential lawsuit against SNY. Based on history of not living up to their contractual obligations at patients and investors' expense. Entering contract with the possible intent of destroying MNKD. From Reuters.....sound familiar:
"The trustee further claims that even after Lemtrada was finally approved in November 2014, Sanofi skimped on marketing it, while actively promoting a different multiple sclerosis drug, Aubagio. As a result, the lawsuit says, Lemtrada has failed to meet any of the sales benchmarks."
reuters.com/article/2015/11/09/sanofi-genzyme-lawsuit-idUSL1N13433H20151109
Sounds like a potential lawsuit against SNY. Based on history of not living up to their contractual obligations at patients and investors' expense. Entering contract with the possible intent of destroying MNKD. From Reuters.....sound familiar:
"The trustee further claims that even after Lemtrada was finally approved in November 2014, Sanofi skimped on marketing it, while actively promoting a different multiple sclerosis drug, Aubagio. As a result, the lawsuit says, Lemtrada has failed to meet any of the sales benchmarks."
reuters.com/article/2015/11/09/sanofi-genzyme-lawsuit-idUSL1N13433H20151109